These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study]. Schillaci G, Verdecchia P. Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297 [No Abstract] [Full Text] [Related]
3. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474 [Abstract] [Full Text] [Related]
5. [Recent intervention studies with antihypertensive drugs and their influence on guidelines]. Rahn KH. Med Klin (Munich); 2003 Dec 15; 98(12):771-5. PubMed ID: 14685679 [Abstract] [Full Text] [Related]
12. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group. Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936 [Abstract] [Full Text] [Related]
15. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. Parra D, Rosenstein R. N Engl J Med; 2009 Mar 12; 360(11):1147-8; author reply 1149-50. PubMed ID: 19279348 [No Abstract] [Full Text] [Related]
16. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB, ALLHAT Collaborative Research Group. JAMA; 2005 Apr 06; 293(13):1595-608. PubMed ID: 15811979 [Abstract] [Full Text] [Related]
17. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK. Pharmacogenet Genomics; 2009 Jun 06; 19(6):415-21. PubMed ID: 19352213 [Abstract] [Full Text] [Related]
18. Diuretics: older, cheaper, better. Johns Hopkins Med Lett Health After 50; 2003 Apr 06; 15(2):1-2. PubMed ID: 12712964 [No Abstract] [Full Text] [Related]